URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Asbury

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Agents
24
1982
625
2.910
Why?
Imides
6
1993
7
1.780
Why?
Isoquinolines
6
1993
63
1.740
Why?
Thiadiazoles
7
1986
13
1.370
Why?
Uterine Neoplasms
5
1990
103
1.270
Why?
Antineoplastic Combined Chemotherapy Protocols
13
1985
430
0.860
Why?
Uterine Cervical Neoplasms
4
1987
124
0.830
Why?
Carcinoma
5
1989
191
0.820
Why?
Endometrial Neoplasms
3
1996
37
0.820
Why?
Colonic Neoplasms
6
1985
123
0.740
Why?
Carcinoma, Squamous Cell
4
1987
232
0.670
Why?
Neoplasm Recurrence, Local
5
1989
286
0.660
Why?
Lung Neoplasms
10
1983
428
0.650
Why?
Mixed Tumor, Mesodermal
2
1996
2
0.620
Why?
Leiomyosarcoma
2
1995
18
0.590
Why?
Adenocarcinoma
8
1985
423
0.520
Why?
Paclitaxel
5
1995
57
0.510
Why?
Carcinoma, Non-Small-Cell Lung
5
1994
71
0.490
Why?
Middle Aged
34
1980
9877
0.480
Why?
Etoposide
9
1983
83
0.460
Why?
Aged
28
1984
7272
0.460
Why?
Ovarian Neoplasms
4
1984
107
0.450
Why?
Goserelin
1
2002
7
0.450
Why?
Naphthalimides
6
1993
9
0.450
Why?
Antineoplastic Agents, Hormonal
1
2002
46
0.430
Why?
Female
40
1981
19826
0.420
Why?
Topotecan
1
2000
4
0.370
Why?
Esophageal Neoplasms
1
2000
57
0.340
Why?
Adult
24
1984
11345
0.340
Why?
Humans
46
1980
36400
0.340
Why?
Drug Administration Schedule
10
1984
369
0.310
Why?
Remission Induction
8
1989
163
0.290
Why?
Rectal Neoplasms
3
1985
83
0.280
Why?
Breast Neoplasms
8
1981
675
0.270
Why?
Antineoplastic Agents, Phytogenic
4
1996
39
0.270
Why?
Neoplasm Metastasis
7
1981
229
0.270
Why?
Drug Evaluation
9
1984
101
0.250
Why?
Carboplatin
6
1989
30
0.230
Why?
Pancreatic Neoplasms
1
1994
84
0.230
Why?
Cisplatin
4
1986
94
0.200
Why?
Survival Analysis
5
1994
598
0.200
Why?
Spiro Compounds
3
1988
5
0.190
Why?
Ifosfamide
5
1994
8
0.190
Why?
Fluorouracil
3
1986
76
0.190
Why?
Organometallic Compounds
3
1988
71
0.190
Why?
Aged, 80 and over
5
1996
2513
0.180
Why?
Organoplatinum Compounds
1
1989
6
0.180
Why?
Infusions, Intravenous
4
1987
139
0.180
Why?
Mitoxantrone
4
1984
20
0.170
Why?
Stomach Neoplasms
2
1999
35
0.170
Why?
Male
22
1980
19713
0.170
Why?
Mitomycins
2
1985
17
0.170
Why?
Carcinoma, Small Cell
2
1983
32
0.150
Why?
Neoplasm Staging
4
1996
335
0.150
Why?
Aclarubicin
2
1994
5
0.150
Why?
Folic Acid
1
1987
21
0.150
Why?
Aminoglutethimide
2
1981
6
0.140
Why?
Methotrexate
1
1985
71
0.130
Why?
Neoplasms
3
1992
723
0.120
Why?
Leukopenia
4
1984
25
0.120
Why?
Podophyllotoxin
1
1983
10
0.120
Why?
Allopurinol
2
1987
10
0.110
Why?
Hematologic Diseases
3
1985
37
0.100
Why?
Thrombocytopenia
3
1989
76
0.100
Why?
Budd-Chiari Syndrome
1
1980
9
0.090
Why?
Dacarbazine
1
1980
21
0.090
Why?
Drug-Induced Liver Injury
1
1980
36
0.090
Why?
Nausea
3
1981
155
0.090
Why?
Trimetrexate
1
1999
1
0.090
Why?
Antimetabolites, Antineoplastic
1
1999
38
0.090
Why?
Harringtonines
1
1999
2
0.090
Why?
Hydroxyurea
1
1999
14
0.090
Why?
Interferon-beta
1
1999
63
0.080
Why?
Vomiting
3
1982
116
0.080
Why?
Interleukin-2
1
1999
194
0.080
Why?
Survival Rate
3
1991
619
0.080
Why?
Sarcoma
2
1995
63
0.080
Why?
Colorectal Neoplasms
1
1999
136
0.070
Why?
Pilot Projects
4
1986
441
0.070
Why?
Gout Suppressants
1
1996
7
0.070
Why?
Radiation-Sensitizing Agents
1
1996
72
0.070
Why?
Lymphoma
2
1990
163
0.070
Why?
Uric Acid
1
1996
50
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
41
0.070
Why?
Mitomycin
2
1985
18
0.070
Why?
Carcinoma, Adenoid Cystic
1
1995
10
0.070
Why?
Mesna
1
1994
2
0.060
Why?
Head and Neck Neoplasms
1
1995
84
0.060
Why?
Pelvic Neoplasms
1
1994
15
0.060
Why?
Chemotherapy, Adjuvant
1
1994
88
0.060
Why?
Treatment Outcome
3
1994
2623
0.060
Why?
Vincristine
3
1986
61
0.060
Why?
Adjuvants, Immunologic
1
1994
120
0.060
Why?
Diarrhea
2
1987
64
0.050
Why?
Oncologic Nursing
1
1992
8
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Drug Therapy
1
1992
46
0.050
Why?
Medical Oncology
1
1992
49
0.050
Why?
Behavior Therapy
1
1992
109
0.050
Why?
Melphalan
1
1990
27
0.050
Why?
Multicenter Studies as Topic
1
1990
128
0.040
Why?
Anemia
1
1990
77
0.040
Why?
Random Allocation
1
1989
254
0.040
Why?
Leukemia, Myelomonocytic, Acute
1
1988
11
0.040
Why?
Hydrocortisone
1
1989
131
0.040
Why?
Bone Marrow Transplantation
1
1990
186
0.040
Why?
Catheterization, Central Venous
1
1988
59
0.040
Why?
Stomach
1
1988
67
0.040
Why?
Intestine, Small
1
1988
111
0.040
Why?
Prognosis
1
1989
1080
0.030
Why?
Skin Neoplasms
1
1988
231
0.030
Why?
Injections, Intravenous
2
1990
131
0.030
Why?
Anthraquinones
1
1984
7
0.030
Why?
Liver Neoplasms
1
1986
152
0.030
Why?
Melanoma
2
1980
135
0.030
Why?
Drug Therapy, Combination
2
1989
390
0.030
Why?
Prostatic Neoplasms
1
1989
556
0.030
Why?
Drug Resistance
1
1983
101
0.030
Why?
Sleep Stages
1
1981
19
0.030
Why?
Hormones
1
1981
64
0.020
Why?
Combined Modality Therapy
2
1986
486
0.020
Why?
Mitolactol
2
1989
6
0.020
Why?
Thiotepa
2
1989
7
0.020
Why?
Vinblastine
2
1989
27
0.020
Why?
Necrosis
1
1980
105
0.020
Why?
Dexamethasone
1
1981
183
0.020
Why?
Doxorubicin
2
1989
109
0.020
Why?
Antibiotics, Antineoplastic
1
1999
48
0.020
Why?
Drug Resistance, Neoplasm
1
1999
56
0.020
Why?
Safety
1
1999
101
0.020
Why?
Salvage Therapy
1
1999
60
0.020
Why?
Pain
1
1981
382
0.020
Why?
Ascitic Fluid
1
1996
22
0.020
Why?
Disease Progression
1
1999
519
0.020
Why?
Alopecia
1
1996
20
0.020
Why?
Treatment Failure
1
1996
130
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
1996
46
0.020
Why?
Fever
1
1996
100
0.020
Why?
Neutropenia
1
1996
57
0.020
Why?
Liver
1
1980
876
0.020
Why?
Cohort Studies
1
1999
969
0.020
Why?
Follow-Up Studies
2
1986
1857
0.020
Why?
Kidney
1
1996
582
0.010
Why?
Retrospective Studies
1
1999
2260
0.010
Why?
Time Factors
2
1989
3201
0.010
Why?
Cyclophosphamide
1
1991
173
0.010
Why?
Biological Availability
1
1990
40
0.010
Why?
Carmustine
1
1990
37
0.010
Why?
Fluoxymesterone
1
1989
4
0.010
Why?
Randomized Controlled Trials as Topic
1
1992
409
0.010
Why?
Administration, Oral
1
1990
309
0.010
Why?
Hematoma
1
1988
40
0.010
Why?
Motilin
1
1988
3
0.010
Why?
Periodicity
1
1988
41
0.010
Why?
Nervous System Diseases
1
1989
147
0.010
Why?
Palliative Care
1
1989
159
0.010
Why?
Dogs
1
1988
488
0.010
Why?
Electrophysiology
1
1988
247
0.010
Why?
Behavior, Animal
1
1988
238
0.010
Why?
Animals
1
1988
16270
0.000
Why?

Visualizations


Asbury's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department